Seminar to Discuss New Treatment Option for Severe Asthma
Mishawaka, Ind. (July 18, 2013) – Those who suffer from severe asthma may find relief due to a new non-drug, outpatient procedure offered at the Saint Joseph Regional Medical Center Mishawaka Campus.
Bronchial Thermoplasty (BT) is a FDA-approved procedure for the treatment of severe, persistent asthma in patients 18 years and older whose asthma is not well controlled with inhaled corticosteroids or long-acting beta-agonists.
Performed under moderate sedation or light anesthesia, this minimally invasive bronchoscopic procedure is performed by a trained physician, typically a pulmonologist. The procedure is performed in three outpatient visits, scheduled approximately three weeks apart, each treating a different area of the lungs. After all three procedures are performed; the bronchial thermoplasty treatment is complete.
"Treatment using this procedure has been shown to improve the quality of life for those suffering from severe asthma by reducing asthma attacks, decreasing visits to the emergency room and less lost time from work, school, or other activities,” says Paul Guentert, MD, of Pulmonary & Critical Care Associates.
The community is invited to a free seminarnext week to learn more about BT from someone who has experienced it firsthand. Featured speaker Tony Cook was the first patient treated with BT after it was approved by the FDA. Tony says the procedure has left him “basically asthma free.” He will be on hand to tell his experience with BT and answer questions from patients considering this treatment.
What: Asthma Treatment Seminar When: Thursday, July 25, 5:30 – 6:30 pm Where: Mishawaka Campus - Education Center A, 5215 Holy Cross Parkway, Mishawaka, IN 46545
Registration is not required.
For more information about BT, call Pulmonary & Critical Care Associates at 574-246-9350. Click to read more about BT in the Michiana Medical Update.